➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Express Scripts
Harvard Business School
McKinsey
Baxter

Last Updated: April 20, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OMNARIS

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Omnaris

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00458835 Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422) Completed AstraZeneca Phase 4 2007-04-01 The purpose of this study is to compare the systemic des-ciclesonide exposure of OMNARIS™ (ciclesonide) nasal spray, ciclesonide HFA nasal aerosol, and orally inhaled ciclesonide HFA-metered-dose inhaler (MDI). The administration of the study medication will be as follows: three single doses, separated by a wash-out period. The study will provide further data on the safety and tolerability of ciclesonide.
NCT01033825 Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis Completed Sunovion Phase 3 2010-01-01 To demonstrate the effects of ciclesonide applied as a nasal aerosol and ciclesonide aqueous (AQ) nasal spray on hypothalamic-pituitary-adrenal axis.
NCT01430260 Omnaris Versus Levocetirizine Phase 4 Study Completed Takeda Phase 4 2011-01-01 This i a comparison of the efficacy ciclesonide nasal spray and levocetirizine, alone and in combination.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Omnaris

Condition Name

Condition Name for Omnaris
Intervention Trials
Allergic Rhinitis 3
Seasonal Allergic Rhinitis 2
Perennial Allergic Rhinitis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Omnaris
Intervention Trials
Rhinitis, Allergic 7
Rhinitis 7
Rhinitis, Allergic, Seasonal 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Omnaris

Trials by Country

Trials by Country for Omnaris
Location Trials
United States 23
Russian Federation 1
Korea, Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Omnaris
Location Trials
Texas 3
Pennsylvania 2
New Jersey 2
Minnesota 2
Massachusetts 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Omnaris

Clinical Trial Phase

Clinical Trial Phase for Omnaris
Clinical Trial Phase Trials
Phase 4 4
Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Omnaris
Clinical Trial Phase Trials
Completed 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Omnaris

Sponsor Name

Sponsor Name for Omnaris
Sponsor Trials
Takeda 2
Sunovion 2
Apotex Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Omnaris
Sponsor Trials
Industry 7
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Baxter
McKinsey
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.